ArticleResearch square2020

JAK-Inhibitor and Type I Interferon Ability to Produce Favorable Clinical Outcomes in COVID-19 Patients: A Systematic Review and Meta-Analysis.

Lucas Walz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.